MyFinsight
Home
Compare
Blog
About
Avalyn Pharma Inc. (AVLN)
Avalyn Pharma Inc. (AVLN)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$171,887K
Free Cash flow
-$26,345K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from initial public off...
Maturities of marketable securit...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Payment of offering costs
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
Net loss
-28,935
-26,869
Depreciation
110
63
Non-cash operating lease expense
112
109
Stock-based compensation expense
2,790
1,193
Amortization and accretion of premiums/discounts on marketable securities
180
237
Amortization of debt discount and deferred financing costs
17
5
Prepaid expenses and other current assets
-316
508
Other assets
12
0
Accounts payable
-93
-1,113
Accrued liabilities
-79
-2,464
Operating lease liability
-122
-70
Net cash used in operating activities
-26,076
-29,891
Purchases of property and equipment
269
318
Purchases of marketable securities
134,832
0
Proceeds from sale of marketable securities
1
26,342
Maturities of marketable securities
16,390
29,000
Net cash provided by investing activities
-118,710
55,024
Proceeds from initial public offering, net of underwriter discounts and commissions paid during the period
320,850
-
Payment of offering costs
4,136
-
Proceeds from the exercise of stock options
4
25
Proceeds from term loan
0
15,000
Payments of issuance costs associated with term loan
45
163
Proceeds from issuance of series d convertible preferred stock, net of issuance costs
0
-
Net cash provided by financing activities
316,673
14,862
Increase (decrease) in cash and cash equivalents
171,887
39,995
Beginning of period
92,310
52,315
End of period
264,197
92,310
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from initial
public offering, net of...
$320,850K
Proceeds from the
exercise of stock options
$4K
Net cash provided by
financing activities
$316,673K
Canceled cashflow
$4,181K
Increase (decrease) in
cash and cash...
$171,887K
Canceled cashflow
$144,786K
Payment of offering
costs
$4,136K
Payments of issuance
costs associated with...
$45K
Maturities of marketable
securities
$16,390K
Proceeds from sale of
marketable securities
$1K
Stock-based compensation
expense
$2,790K
Prepaid expenses and
other current assets
-$316K
Non-cash operating lease
expense
$112K
Depreciation
$110K
Amortization of debt discount
and deferred...
$17K
Net cash provided by
investing activities
-$118,710K
Net cash used in
operating activities
-$26,076K
Canceled cashflow
$16,391K
Canceled cashflow
$3,345K
Purchases of marketable
securities
$134,832K
Net loss
-$28,935K
Purchases of property and
equipment
$269K
Amortization and accretion of
premiums/discounts on marketable...
$180K
Operating lease liability
-$122K
Accounts payable
-$93K
Accrued liabilities
-$79K
Other assets
$12K
Buy us a coffee